digital currency stock market, People searches

The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)CITIC Bank: Redemption of open-ended capital bonds. CITIC Bank announced that from December 9 to December 11, 2019, it issued RMB 40 billion of open-ended capital bonds (hereinafter referred to as "current bonds"), and on December 12, 2019, it issued the Announcement of China CITIC Bank Corporation on the Completion of Issuance of Open-ended Capital Bonds. According to the relevant provisions of the prospectus of this issue, this issue has the issuer's conditional redemption right, and the issuer has the right to redeem this issue in whole or in part on the interest payment date of the fifth year of this issue, that is, December 11, 2024. As of the date of this announcement, with the approval of the State Financial Supervision and Administration, the Bank has exercised the right of redemption and redeemed the bonds in full.Beijing Auto: BAIC Investment and Hyundai Motor invested US$ 1.095 billion in Beijing Hyundai. Beijing Auto announced that on December 11, 2024, BAIC Investment and Hyundai Motor entered into an agreement, and both parties agreed to jointly invest US$ 1.095 billion in Beijing Hyundai according to the proportion of their respective registered capital, and both parties invested US$ 548 million respectively. The capital injection will be carried out in stages. After the capital injection is completed, the registered capital of Beijing Hyundai will increase to US$ 4.074 billion, and Beijing Hyundai will still be owned by BAIC Investment and Hyundai Motor respectively, and will continue to be accounted for as a joint venture of the Company.

Jinfei Kaida: The controlling shareholder plans to increase the company's shares by RMB 50 million to RMB 100 million. Jinfei Kaida (002863) announced on the evening of December 11th that the controlling shareholder Jinfei Holdings plans to increase the company's shares by RMB 50 million to RMB 100 million. Jinhua Branch of China Construction Bank Co., Ltd. issued the "China Construction Bank Loan Commitment Letter" to Jinfei Holdings on December 10th, promising to provide Jinfei Holdings with a special loan of no more than 90 million yuan for stock increase, with a loan period of 3 years.Pinduoduo stocks fell more than 3% before trading.Kremlin: We keep in touch with those who control the situation in Syria.

The International Finance Association predicts that the capital flowing into emerging markets will decrease by 24% in 2025, and the International Finance Association predicts that the capital flowing into emerging markets will decrease by 24% to $716 billion in 2025. It is estimated that in 2025, Mexico's portfolio inflow will drop by a quarter to $1 billion, and in 2025, India's portfolio inflow will more than triple to $22 billion.Health Yuan: Obtained the commitment letter of stock repurchase loan from financial institutions of no more than 238 million yuan. Health Yuan announcement, the company recently obtained the commitment letter of loan from Industrial Bank, with a loan amount of no more than 238 million yuan, no more than 90% of the upper limit of repurchase amount, and a loan period of no more than 36 months, which is specially used to repurchase shares of listed companies. The total amount of the company's actual loan and the amount of the repurchased funds shall not exceed the upper limit of the amount of this repurchase program. The commitment letter of the financial institution's stock repurchase loan obtained this time does not represent the company's commitment to the repurchase amount. The specific number of shares repurchased shall be subject to the actual number of shares repurchased at the expiration of the repurchase period.Health Yuan: Obtained the commitment letter of stock repurchase loan from financial institutions of no more than 238 million yuan. Health Yuan announcement, the company recently obtained the commitment letter of loan from Industrial Bank, with a loan amount of no more than 238 million yuan, no more than 90% of the upper limit of repurchase amount, and a loan period of no more than 36 months, which is specially used to repurchase shares of listed companies. The total amount of the company's actual loan and the amount of the repurchased funds shall not exceed the upper limit of the amount of this repurchase program. The commitment letter of the financial institution's stock repurchase loan obtained this time does not represent the company's commitment to the repurchase amount. The specific number of shares repurchased shall be subject to the actual number of shares repurchased at the expiration of the repurchase period.